ABBVIE
A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion
- Conditions
- Interventions
- First Posted Date
- 2013-06-28
- Last Posted Date
- 2021-12-16
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 158
- Registration Number
- NCT01889186
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey /ID# 92513, New Brunswick, New Jersey, United States
🇺🇸Hackensack Univ Med Ctr /ID# 92500, Hackensack, New Jersey, United States
🇦🇺Peter MacCallum Cancer Ctr /ID# 91795, Melbourne, Victoria, Australia
Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease
- Conditions
- First Posted Date
- 2013-05-23
- Last Posted Date
- 2017-06-16
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 106
- Registration Number
- NCT01860846
Study Of Diabetic Nephropathy With Atrasentan
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 5107
- Registration Number
- NCT01858532
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
- Conditions
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 1310
- Registration Number
- NCT01858519
- Locations
- 🇺🇸
Site Reference ID/Investigator# 116382, Anchorage, Alaska, United States
🇺🇸Site Reference ID/Investigator# 116595, Long Beach, California, United States
🇺🇸Site Reference ID/Investigator# 116441, Hartford, Connecticut, United States
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2017-11-21
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 71
- Registration Number
- NCT01853306
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults
- Conditions
- Interventions
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 148
- Registration Number
- NCT01854528
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
- Conditions
- Interventions
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 311
- Registration Number
- NCT01854697
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis
- First Posted Date
- 2013-05-14
- Last Posted Date
- 2017-11-20
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 19
- Registration Number
- NCT01853033
- Locations
- 🇺🇸
Site Reference ID/Investigator# 118964, Duncansville, Pennsylvania, United States
🇺🇸Site Reference ID/Investigator# 107115, Raleigh, North Carolina, United States
🇺🇸Site Reference ID/Investigator# 100780, Dallas, Texas, United States
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
- Conditions
- First Posted Date
- 2013-05-07
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 8250
- Registration Number
- NCT01848561
- Locations
- 🇺🇸
Greenville Endoscopy Center /ID# 129900, Greenville, South Carolina, United States
🇺🇸Mid-State Gastroenterology /ID# 125457, Murfreesboro, Tennessee, United States
🇩🇪Universitaetsklinikum Jena /ID# 127496, Jena, Thueringen, Germany
Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
- Conditions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2019-01-09
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 183
- Registration Number
- NCT01845818